The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism

Neurology

Volumn 60, Issue 1, 2003, Pages 87-93

  Pressley, J C ^a   Louis, E D ^a   Tang, M X ^a   Cote, L ^a   Cohen, P D ^a   Glied, S ^a   Mayeux, R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTHRITIS; ARTICLE; CANCER; COMORBIDITY; DEMENTIA; DIABETES MELLITUS; FEMALE; FRACTURE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIP FRACTURE; HUMAN; HYPERTENSION; INJURY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICARE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; STROKE;

EID: 0037435524     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.60.1.87     Document Type: Article

References (31)

1. Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch Neurol 1992;49:492-497.
2. Gorell JM, Johnson CC, Rybicki BA. Parkinson disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990. Neurology 1994;44:1865-1868.
3. Rajput AH. Parkinson's disease and related disorders. In: Hazzard WR, Blass JP, Ettinger WH, Halter JB, Ouslander JG, eds. Principles of geriatric medicine and gerontology, 4th ed. New York: McGraw Hill, 1998;1271-1281.
4. Whetten-Goldstein K, Sloan F, Kulas E, Cutson T, Schenkman M. The burden of Parkinson disease on society, family, and the individual. J Am Geriatr Soc 1997;45:844-849.
5. Dodel RC, Eggert KM, Singer MS, Eichhorn TE, Pogarell O, Oertel WH. Costs of drug treatment in Parkinson's disease. Mov Disord 1998;13:249-254.
6. Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky RL. The health burdens of Parkinson's disease. Mov Disord 1998;13:406-413.
7. Department of Health and Human Services, National Institutes of Health. Disease-specific estimates of direct and indirect costs of illness and NIH support, Department of Health and Human Services, National Institutes of Health, February 2000. Available at: http://wwwl.od. nih.gov/osp/ecostudies/COIreportweb.htm. Accessed June 2000.
8. National Technical Information Service. National Long Term Care Survey. Washington, DC: US Government Printing Office, 1989.
9. Pressley JC. Factors impacting functional state and health care utilization in the elderly [dissertation]. Durham, NC: Duke University, 1996.
10. Manton KG, Corder LS, Stallard E. Estimates of change in chronic disability and institutional incidence and prevalence rates in the U.S. elderly population from the 1982, 1984, and 1989 National Long Term Care Survey. J Gerontol Soc Sci 1993;48:S153-S166.
11. World Health Organization. ICD-9-CM diseases, vol. 1 and 2, 8th ed. New York: McGraw-Hill, 1999.
12. Kandel ER, Schwartz JH, Jessell TM, eds. Principles of neural science, 3rd ed. Norwalk: Appleton & Lange, 1991.
13. Department of Health and Human Services, Agency for Health Care Policy and Research. Clinical classifications for health policy research. Tools for decisionmaking and research (AHCPR pub. no. 98-0049). Rockville, MD: Department of Health and Human Services, Agency for Health Care Policy and Research, 1999.
14. Goldstein LB. Accuracy of ICD-9-CM coding for identification of patients with acute ischemic stroke: effect of modifier codes. Stroke 1998;29:1602-1604.
15. Benesch C, Witter DM, Wilder AL, et al. Inaccuracy of the ICD-9-CM in identifying the diagnosis of ischemic cerebrovascular disease. Neurology 1997;49:660-664.
16. Reker DM, Rosen AK, Hoenig H, et al. The hazards of stroke case selection using administrative data. Med Care 2002;40:96-104.
17. Leibson CL, Naessens JM, Brown RD, Whisnant JP. Accuracy of hospital discharge abstracts for identifying stroke. Stroke 1994;25:2348-2355.
18. Uitti RJ, Ahlskog JE, Maraganore DM, et al. Levodopa therapy and survival in idiopathic Parkinson disease: Olmsted County project. Neurology 1993;43:1918-1926.
19. Kurtzke JF, Murphy FM. The changing patterns of death rates in parkinsonism. Neurology 1990;40:42-49.
20. Marttila RJ, Rinne UK. Progression and survival in Parkinson's disease. Acta Neurol Scand 1991;136S:24-28.
21. Poewe WH, Wenning GK. The natural history of Parkinson disease. Ann Neurol 1998;44:S1-S9.
22. Rybicki BA, Johnson CC, Gorell JM. Demographic differences in referral rates to neurologists of patients with suspected Parkinson disease: implications for case-control study design. Neuroepidemiology 1995;14:72-81.
23. Johnell O, Melton LJ III, Atkinson EJ, O'Fallon WM, Kurland LT. Fracture risk in patients with parkinsonism: a population-based study in Olmsted County, Minnesota. Age Ageing 1992;21:32-38.
24. Lord S. Instability and falls in elderly people. In: Lafont C, Baroni A, Allard M, et al., eds. Falls, gait and balance disorders in the elderly. New York: Springer, 1996;125-139.
25. Sandyk R. The relationship between diabetes mellitus and Parkinson's disease. Int J Neurosci 1993;69:125-130.
26. Lechner H, Bertha G. Parkinsonism with a high vascular risk - Lechner-Ott syndrome. Wien Med Wochenschr 1986;136:387-391.
27. Barbeau A, Pourcher E. New data on the genetics of Parkinson disease. Can J Neurol Sci 1982;9:53-60.
28. Saeki H, Muneta S, Kobayashi T. Malignant syndrome associated with disseminated intravascular coagulation and a high level of amylase in serum, followed by diabetic coma in an elderly patient with Parkinson disease during L-dopa therapy. Nippon Ronen Igakkai Zasshi 1998;35:139-144.
29. Pressley JC, Patrick D, George LK, Lipscomb J. The relation between cardiac disease severity, health expenditures, and income in Medicare patients. Health Star, National Library of Medicine, 1997. Available at: http://www.igm.nlm.nih.gov.
30. Jollis JG, Ancukiewicz M, DeLong ER, Pryor DB, Muhlbaier L, Mark DB. Discordance of databases designed for claims payment vs clinical information systems. Ann Intern Med 1993;119:844-850.
31. Hsia DC, Drushat WM, Fagan AB, Tebbut JA, Kusserow RP. Accuracy of diagnostic coding for Medicare patients under the prospective payment system. N Engl J Med 1988;318:352-355.